Updated 07 August 2026 · HodieLabs Clinical Governance Lead · The HodieLabs Evidence-Based Clinical Library
A pancreatic enzyme; elevated levels may indicate pancreatic inflammation. Lipase is measured by blood test as part of the Organ panel in the HodieLabs Health Blueprint.
Optional. Interpret using the reporting lab’s reference interval and clinical context; trend over time is often more informative than a single value.
Associated risks when out of range: Elevated lipase (>3× upper limit) is diagnostic of acute pancreatitis. Mildly elevated lipase may indicate chronic pancreatitis, pancreatic duct obstruction, or renal impairment.
The HodieLabs Evidence-Based Clinical Library classifies Lipase as an strong evidence-tier biomarker. Its reference ranges come from a published authority standard rather than from observational optimisation targets. The standard used here is RCPA Australian pathology reference intervals; lipase <60 U/L normal. >3× ULN diagnostic for acute pancreatitis. Where relevant clinical outcomes are noted on this page, they reflect the guideline literature referenced below.
The HodieLabs Evidence-Based Clinical Library interprets Lipase against published clinical authority standards, never arbitrary "optimal" ranges. Measured in U/L:
Recommended testing frequency: Annual, as part of a comprehensive panel. Single markers are always interpreted in context.
Lipase is measured in every Health Blueprint at our Melbourne Preventative Health & Longevity Clinic, interpreted by a doctor against the guideline-cited ranges above and tracked over time through your HodieLabs membership.
1. RCPA Australian pathology reference intervals; lipase <60 U/L normal. >3× ULN diagnostic for acute pancreatitis.
This page is general information from the HodieLabs Evidence-Based Clinical Library, not medical advice. Speak with your GP about what testing and care is appropriate for you.
A pancreatic enzyme; elevated levels may indicate pancreatic inflammation.
The HodieLabs Evidence-Based Clinical Library optimal range is <60 U/L, based on RCPA Australian pathology reference intervals; lipase <60 U/L normal. >3× ULN diagnostic for acute pancreatitis.
Annual testing is recommended for most adults as part of a comprehensive preventative panel; more often if a result is being actively managed.
Evidence-supported levers include: lipase >3× upper limit: urgent clinical assessment for acute pancreatitis, mildly elevated: investigate with imaging (ct/mri) and clinical correlation. Interpretation and an action plan should always involve your doctor.
Lipase is measured in the HodieLabs Health Blueprint at our Melbourne Preventative Health and Longevity Clinic at 85 Spring Street, with doctor-led interpretation against evidence-based reference ranges.
Lipase and 50+ biomarkers, measured and doctor-interpreted at our Melbourne clinic.